NasdaqCM - Delayed Quote USD

RedHill Biopharma Ltd. (RDHL)

0.4280 +0.0093 (+2.22%)
At close: 4:00 PM EDT
0.4307 +0.00 (+0.63%)
After hours: 5:06 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----11
Avg. Estimate ----20.8M38M
Low Estimate ----20.8M38M
High Estimate ----20.8M38M
Year Ago Sales ------20.8M
Sales Growth (year/est) ------82.70%

Earnings History

CURRENCY IN USD 3/31/2022 6/30/2022
EPS Est. -----0.23-0.03
EPS Actual -----0.3-0.2
Difference -----0.07-0.17
Surprise % -----30.40%-566.70%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 000.140.28
30 Days Ago 000.140.28
60 Days Ago 000.140.28
90 Days Ago 000.140.28

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD RDHLIndustrySectorS&P 500
Current Qtr. ------6.50%
Next Qtr. ------12.00%
Current Year ------5.30%
Next Year ------13.10%
Next 5 Years (per annum) ------11.09%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

760.00
760.00 Average
0.4280 Current
760.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Related Tickers